BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

PRELUDE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001387508)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 60,897 Value ($000) $546 Avg Close $9.31 Range $6.02 - $11.31
Q1 2025
Shares 99,900 Value ($000) $749 Avg Close $8.07 Range $6.96 - $9.50
Q3 2024
Shares 38,900 Value ($000) $296 Avg Close $7.60 Range $6.17 - $8.88
Q1 2020
Shares 24,433 Value ($000) $49 Avg Close $2.75 Range $1.58 - $4.35
Q2 2019
Shares 3,587 Value ($000) $14 Avg Close $6.02 Range $2.80 - $9.26
Q3 2018
Shares 1,318 Value ($000) $10 Avg Close $6.72 Range $5.41 - $8.13
Q1 2017
Shares 800 Value ($000) $7 Avg Close $6.96 Range $4.20 - $9.25
Q2 2016
Shares 24,700 Value ($000) $70 Avg Close $3.10 Range $2.49 - $4.03
Q1 2016
Shares 6,000 Value ($000) $17 Avg Close $4.43 Range $1.63 - $10.24
Q1 2015
Shares 800 Value ($000) $7 Avg Close $10.35 Range $7.85 - $12.71
Q4 2014
Shares 4,500 Value ($000) $55 Avg Close $11.05 Range $9.02 - $13.28
Q3 2014
Shares 3,300 Value ($000) $32 Avg Close $12.26 Range $9.78 - $14.62
Q2 2014
Shares 2,600 Value ($000) $33 Avg Close $9.73 Range $7.29 - $12.86